Zynex Inc. (ZYXI)

[rado]

Looks like this might be accounting for a little extra push today. He is targeting $9

https://seekingalpha.com/instablog/498952-bret-jensen/5299098-4-biotech-stocks-analysts-say-buy-wednesday

B Riley FBR maintains its Buy rating and $9 price target on Zynex (OTC:ZYXI) after that company reported quarterly results. Here is their view on the firm's first quarter.

"Buy-rated Zynex, Inc. reported 1Q results that continued its impressive turnaround story as the company posted its 11th consecutive quarter of positive net income. New orders for the company’s NexWave electrotherapy pain management device were up 30% and revenues of $9.2M easily topped management’s $8.3M-$8.8M guide despite a seasonally weaker 1Q in which healthcare deductibles generally remain unmet. The opioid epidemic plaguing the US has kept demand strong and reimbursement rates high for ZYXI’s NexWave, which according to management has no discernible side effects. Management appears to be boring full steam ahead with expansion of its sales force in order to fill the void left by the two largest players exiting the market at the end of 2015/early 2016."